Stock BVNRY BAVARIAN NORDIC A/S
Add to a list
To use this feature you must be a member
Log inSign up

Company Bavarian Nordic A/S OTC Markets

Equities

BVNRY

US0717711099

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 15:30:54 2024-06-10 EDT 		5-day change 1st Jan Change
8.52 USD -1.73% Intraday chart for Bavarian Nordic A/S -4.49% -2.57%
05-31 Bavarian Nordic Files for Supplemental US License for Smallpox-Monkeypox Vaccine MT
05-30 Bavarian Nordic Gets $6.5 Million Funding for Development of Mpox Vaccine in Children MT

Business Summary

Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases.

Net sales by revenue source are divided between sales of products (97.8%) and services (2.2%).

Net sales are distributed geographically as follows: the United States (36.5%), Canada (22%), France (10.5%), Germany (10.1%), Spain (6.1%), Australia (4.8%), Switzerland ( 1.5%), Sweden (1%), Chile (0.9%), Taiwan (0.8%), the United Kingdom (0.6%), Hong Kong (0.2%), Saudi Arabia (0.1%), and others (4.9%).

Number of employees: 1,381

Sales per Business

DKK in Million2022Weight2023Weight Delta
Life-Saving Vaccines
100.0 %
3,151 100.0 % 7,062 100.0 % +124.14%

Sales per region

DKK in Million2022Weight2023Weight Delta
United States
36.5 %
842 26.7 % 2,577 36.5 % +206.24%
Canada
22.0 %
197 6.3 % 1,556 22.0 % +688.73%
France
10.5 %
268 8.5 % 740 10.5 % +176.02%
Germany
10.1 %
650 20.6 % 714 10.1 % +9.83%
Spain
6.1 %
-- 430 6.1 % -
Australia
4.8 %
98 3.1 % 338 4.8 % +246.19%
Other
4.6 %
285 9.0 % 326 4.6 % +14.38%
Switzerland
1.5 %
71 2.3 % 108 1.5 % +51.77%
Sweden
1.0 %
-- 72 1.0 % -
Chile
0.9 %
-- 65 0.9 % -
Taiwan
0.8 %
-- 54 0.8 % -
United Kingdom
0.6 %
169 5.4 % 45 0.6 % -73.57%
Denmark
0.3 %
19 0.6 % 19 0.3 % -2.07%
Hong Kong
0.2 %
116 3.7 % 14 0.2 % -87.94%
Saudi Arabia
0.1 %
100 3.2 % 5 0.1 % -95.18%

Managers

Managers TitleAgeSince
Paul Chaplin CEO
 Chief Executive Officer 57 98-12-31
Henrik Juuel DFI
 Director of Finance/CFO 59 18-10-31
Russell Thirsk COO
 Chief Operating Officer 56 22-03-31
Rolf Sass Sørensen IRC
 Investor Relations Contact - -
Anu Helena Kerns HRO
 Human Resources Officer 52 20-10-31
May Jean Christophe PRN
 Corporate Officer/Principal 57 -

Members of the board

Members of the board TitleAgeSince
Anders Gersel Pedersen BRD
 Director/Board Member 73 10-04-26
Johannes van Hoof BRD
 Director/Board Member 57 22-12-31
Frank Verwiel BRD
 Director/Board Member 61 16-04-19
Heidi Hunter BRD
 Director/Board Member 65 22-12-31
Anne Eberhard BRD
 Director/Board Member 61 19-04-23
Luc Debruyne CHM
 Chairman 61 23-02-28
Linette Andersen BRD
 Director/Board Member 50 20-12-31
Thomas Bennekov BRD
 Director/Board Member 56 20-12-31
Anja Gjøl BRD
 Director/Board Member 44 20-12-31
Karen Jensen BRD
 Director/Board Member 65 20-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 78,116,536 78,002,173 ( 99.85 %) 43,954 ( 0.0563 %) 99.85 %

Shareholders

NameEquities%Valuation
ATP Arbejdsmarkedets Tillægspension
9.164 %
7,158,420 9.164 % 193 M $
Nykredit Bank A/S (Investment Management)
1.174 %
916,840 1.174 % 25 M $
Oddo BHF Asset Management SAS
0.5684 %
443,991 0.5684 % 12 M $
AllianceBernstein Ltd.
0.4287 %
334,875 0.4287 % 9 M $
BAVARIAN NORDIC A/S
0.3690 %
288,222 0.3690 % 8 M $
Fundamental Fondsmæglerselskab A/S
0.3138 %
245,137 0.3138 % 7 M $
Dimensional Fund Advisors Ltd.
0.1847 %
144,297 0.1847 % 4 M $
TMF Fund Management SA
0.1834 %
143,300 0.1834 % 4 M $
Danske Bank A/S (Investment Management)
0.1736 %
135,632 0.1736 % 4 M $
Sparinvest SA (Denmark)
0.0858 %
67,003 0.0858 % 2 M $
NameEquities%Valuation
RhumbLine Advisers LP
0.000230 %
538 0.000230 % 4 825 $
GAMMA Investing LLC
0.000017 %
39 0.000017 % 350 $

Holdings

NameEquities%Valuation
BAVARIAN NORDIC A/S
0.37%
 288,222 0.37% 7,754,354 $

Company contact information

Bavarian Nordic A/S

Philip Heymans Alle 3

2900, Hellerup

+45 33 26 83 83

http://www.bavarian-nordic.com
address Bavarian Nordic A/S(BVNRY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Bavarian Nordic A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
180.8 DKK
Average target price
263.2 DKK
Spread / Average Target
+45.62%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+48.39% 765B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.13% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.61% 331B
ABBVIE INC. Stock AbbVie Inc.
+10.00% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.87% 248B
ROCHE HOLDING AG Stock Roche Holding AG
-1.96% 219B
NOVARTIS AG Stock Novartis AG
+11.11% 216B
AMGEN INC. Stock Amgen Inc.
+5.80% 164B
PFIZER, INC. Stock Pfizer, Inc.
-2.50% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BAVA Stock
  4. BVNRY Stock
  5. Company Bavarian Nordic A/S